⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL4169207 | 0.85 | — | — | |
| Allylamine SCHEMBL28828732 | 0.84 | ALDH1A1 (0.64) | — | |
| Allylamine SCHEMBL156788 | 0.84 | — | — | |
| Allylamine SCHEMBL18815995 | 0.84 | ALDH1A1 (0.64) | — | |
| Allylamine SCHEMBL438669 | 0.84 | ALDH1A1 (0.64) | — | |
| Malonic Acid SCHEMBL11167406 | 0.82 | ALDH1A1 (0.53) | — | |
| Succinic Acid SCHEMBL15877803 | 0.82 | LMNA (0.53) | — | |
| Allylamine SCHEMBL8486559 | 0.81 | — | — | |
| Allylamine SCHEMBL175714 | 0.81 | — | — | |
| Allylamine SCHEMBL3433020 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160015731-A1 | A TOPICAL ANTIVIRAL COMPOSITION CONTAINING A LOCAL ANESTHETIC AND METHOD OF MAKING THE SAME | NAL PHARMACEUTICALS, LTD. (CN) | 2016-01-21 | — | — | US | claimed |
| WO-2014159731-A1 | A TOPICAL ANTIVIRAL COMPOSITION CONTAINING A LOCAL ANESTHETIC AND METHOD OF MAKING THE SAME | NAL PHARMACEUTICALS, LTD (CN) | 2014-10-02 | — | — | WO | claimed |
| US-20140171490-A1 | Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients | PHARMALINGT INC. (US) | 2014-06-19 | — | — | US | claimed |
| EP-1848541-A2 | METHOD AND DEVICE FOR OPHTHALMIC ADMINISTRATION OF ACTIVE PHARMACEUTICAL INGREDIENTS | Pharmalight Inc. (US) | 2007-10-31 | — | — | EP | claimed |
| WO-2006082588-A2 | METHOD AND DEVICE FOR OPHTHALMIC ADMINISTRATION OF ACTIVE PHARMACEUTICAL INGREDIENTS | PHARMALIGHT INC. (US) | 2006-08-10 | — | — | WO | claimed |
| US-20050069499-A1 | Foamable compositions, processes of preparing same and uses thereof | PERRIGO ISRAEL PHARMACEUTICALS LTD. (IL) | 2005-03-31 | — | — | US | claimed |
| US-20250144006-A1 | COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS | ELIGO BIOSCIENCE (FR) | 2025-05-08 | — | — | US | disclosed |
| US-12214070-B2 | Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins | ELIGO BIOSCIENCE (FR) | 2025-02-04 | — | — | US | disclosed |
| US-12036310-B2 | Skin rejuvenating composition | Endoderm Laboratories, LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-20230218505-A1 | COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS | ELIGO BIOSCIENCE (FR) | 2023-07-13 | — | — | US | disclosed |
| WO-2023081720-A1 | USES OF PAN BET INHIBITORS | VYNE THERAPEUTICS INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| US-11633348-B2 | Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins | ELIGO BIOSCIENCE (FR) | 2023-04-25 | — | — | US | disclosed |
| US-20220296499-A1 | COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS | ELIGO BIOSCIENCE (FR) | 2022-09-22 | — | — | US | disclosed |
| US-20060034779-A1 | Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same | AGIS INDUSTRIES (1983) LTD. (IL) | 2006-02-16 | — | — | US | disclosed |
| US-20060024243-A1 | Foamable compositions containing nitro-imidazoles, processes for preparing same and methods of treatment utilizing same | AGIS INDUSTRIES (1983) LTD. (IL) | 2006-02-02 | — | — | US | disclosed |
| WO-2005044179-A2 | FORMULATIONS CONTAINING ASTRAGALUS EXTRACTS AND USES THEREOF | HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2005-05-19 | — | — | WO | disclosed |
| US-20050069499-A1 | Foamable compositions, processes of preparing same and uses thereof | PERRIGO ISRAEL PHARMACEUTICALS LTD. (IL) | 2005-03-31 | — | — | US | disclosed |
| WO-2005000248-A2 | COMPOSITIONS AND METHODS FOR SKIN CONDITIONING | GERON CORPORATION (US) | 2005-01-06 | — | — | WO | disclosed |
| US-6432391-B1 | FOR APPLICATION TO COSMETIC SUBSTRATES CHOSEN FROM HUMAN SKIN, KERATINOUS SUBSTANCES, SCALPS, AND LIPS, AND WHICH COMPRISES A LIQUID FATTY PHASE GELLED BY A FATTY POLYAMIDE | L'ORéAL S.A. (FR) | 2002-08-13 | — | — | US | disclosed |
| US-20020044918-A1 | Transparent scented solid cosmetic composition | L'OREAL S.A. (FR) | 2002-04-18 | — | — | US | disclosed |